Anti-VEGF Cancer Therapy in Nephrology Practice-Reference-Cited by-同舟云学术

Anti-VEGF Cancer Therapy in Nephrology Practice

Published:2014 Issue: Volume:2014 Page:1-8
ISSN:2090-214X
Container-title:International Journal of Nephrology
language:en
Short-container-title:International Journal of Nephrology

Author:

Izzedine Hassan¹²

Affiliation:

1. Department of Nephrology, Pitie-Salpetriere Hospital, 75013 Paris, France

2. Department of Nephrology, Monceau Park International Clinic, 75017 Paris, France

Abstract

Expanded clinical experience with the antivascular endothelial growth factor (VEGF) agents has come with increasing recognition of their renal adverse effects. Although renal histology is rarely sought in antiangiogenic-treated cancer patients, kidney damage related to anti-VEGF is now established. Its manifestations include hypertension, proteinuria, and mainly glomerular thrombotic microangiopathy. Then, in nephrology practice, should we continue to perform kidney biopsy, and what should be done with the anti-VEGF agents in case of renal toxicity?

Publisher

Hindawi Limited

Subject

Nephrology

Link

http://downloads.hindawi.com/journals/ijn/2014/143426.pdf

Reference73 articles.

1. Angiogenesis: update 2005

2. Angiogenic targets for potential disorders

3. The balance of autocrine VEGF-A and VEGF-C determines podocyte survival

4. VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management

5. Interstitial Nephritis Secondary to Bevacizumab Treatment in Metastatic Leiomyosarcoma

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case of Carfilzomib-Induced Atypical Hemolytic Uremic Syndrome;Annals of Internal Medicine: Clinical Cases;2024-06-01

2. A phase I dose-finding trial of hyperthermic intraperitoneal docetaxel combined with cisplatin in patients with advanced-stage ovarian cancer;Journal of Gynecologic Oncology;2024

3. Renal Implications of Long-Term Systemic Bevacizumab for Recurrent Respiratory Papillomatosis;Annals of Otology, Rhinology & Laryngology;2023-07-12

4. Hypertension and renal disease prevention before cancer therapy;Cardio-Oncology Practice Manual : a Companion to Braunwald 's Heart Disease;2023

5. Long term outcomes of bevacizumab-associated kidney adverse effects;Journal of Onco-Nephrology;2022-10-24